|
SLC4A7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.426000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.827600E-01 |
| Normal-vs-Stage2 |
2.355200E-03 |
| Normal-vs-Stage3 |
4.152600E-01 |
| Normal-vs-Stage4 |
1.730750E-01 |
| Stage1-vs-Stage2 |
2.38469999999102E-05 |
| Stage1-vs-Stage3 |
1.985980E-01 |
| Stage1-vs-Stage4 |
5.786100E-02 |
| Stage2-vs-Stage3 |
1.064370E-02 |
| Stage2-vs-Stage4 |
9.448100E-02 |
| Stage3-vs-Stage4 |
5.371000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.517000E-01 |
| Normal-vs-AfricanAmerican |
8.272600E-01 |
| Normal-vs-Asian |
5.247400E-01 |
| Caucasian-vs-AfricanAmerican |
7.153800E-01 |
| Caucasian-vs-Asian |
3.723200E-01 |
| AfricanAmerican-vs-Asian |
7.921400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.570800E-01 |
| Normal-vs-Female |
5.147000E-01 |
| Male-vs-Female |
9.002000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.796800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.899180E-01 |
| Normal-vs-Age(61-80Yrs) |
6.951900E-02 |
| Normal-vs-Age(81-100Yrs) |
5.975000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.138370E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.399200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.327800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.153800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.723600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.911800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.662400E-01 |
| Classical-VS-Follicular |
4.54930004778475E-09 |
| Classical-VS-Other |
8.120800E-01 |
| Classical-VS-Normal |
6.213000E-01 |
| Tall-VS-Follicular |
2.458300E-03 |
| Tall-VS-Other |
9.880800E-01 |
| Tall-VS-Normal |
9.736400E-01 |
| Follicular-VS-Other |
8.900200E-02 |
| Follicular-VS-Normal |
2.974300E-04 |
| Other-VS-Normal |
9.717600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.127800E-02 |
| Normal-vs-N1 |
5.917000E-01 |
| N0-vs-N1 |
2.241600E-02 |
|
|
